Trulieve Opens Marco Island Dispensary as Florida Market Share Slips

Marco Island Store Targets High-Income Retirees

Trulieve's Marco Island dispensary at 601 Bald Eagle Drive opened July 18 with a patient base skewing older and wealthier than the state average. Marco Island's median household income is $89,400, 47% above Florida's statewide median. Sixty-one percent of residents are over 55, according to U.S. Census data. The store is Trulieve's first in Collier County south of Naples and the company's third location within a 20-mile radius, following its Naples Fifth Avenue and Immokalee Road stores.

The timing isn't accidental. Florida's medical cannabis patient count grew 4.1% year-over-year to 897,000 active cardholders as of June 2026, per the state Office of Medical Marijuana Use, but new patient registrations in Southwest Florida's coastal counties (Collier, Lee, Charlotte) outpaced the state average by 220 basis points. Trulieve is chasing that delta.

The Marco Island store employs 11 full-time staff. It stocks Trulieve's house flower brands—Cultivar Collection, Sunshine Cannabis, Muse—plus its Bhang chocolate and Momenta sublingual lines. No third-party brands are carried, consistent with Trulieve's vertically integrated model.

Statewide Revenue Per Store Declines 11% Year-Over-Year

Trulieve's Florida dispensaries generated an average of $183,000 in monthly revenue per location in Q2 2026, down from $206,000 in Q2 2025. The 11% decline reflects two pressures: market saturation (Florida now has 612 active dispensaries, up from 487 a year ago) and price compression (average eighth prices fell from $42 to $37 statewide between July 2025 and July 2026, per state transaction data).

Trulieve's Florida market share by unit sales dropped to 38.2% in June 2026 from 42.1% in June 2025, according to OMMU weekly reports. Verano Holdings gained 310 basis points to reach 11.8% share, while Ayr Wellness and Curaleaf each added roughly 100 basis points. Trulieve is opening stores to defend revenue, not to capture new growth.

CEO Kim Rivers said on the July 15 earnings call that the company expects Florida same-store sales to stabilize in Q4 2026 as adult-use ballot measure campaigns (Amendment 3, backed by Trulieve's $12 million contribution) drive patient awareness. That timeline assumes the November 2026 referendum passes with the required 60% supermajority.

Amendment 3 Campaign Spending Tops $18 Million

Trulieve has committed $12.3 million to Smart & Safe Florida, the political committee sponsoring Amendment 3, making it the largest single contributor to the adult-use legalization campaign. The amendment, which would allow adults 21+ to purchase up to 2.5 ounces of cannabis from existing medical dispensaries, leads in polling with 63% support among likely voters, according to a July 10 University of North Florida survey (n=1,204, ±2.8% margin of error).

If Amendment 3 passes, Trulieve's 159 Florida stores would convert to dual-license (medical and adult-use) operations on January 1, 2027, per the amendment's implementation language. The company projects adult-use sales would add $340 million to $410 million in annualized Florida revenue by Q4 2027, assuming 18-month ramp and 28% rec/medical sales mix.

Verano and Curaleaf have each contributed under $500,000 to the campaign. That leaves Trulieve exposed if the ballot measure fails or if adult-use rollout is delayed by litigation—a scenario Florida Attorney General Ashley Moody has signaled by filing a pre-emptive challenge to the amendment's ballot summary language.

Collier County Adds Third Trulieve Within 20 Miles

The Marco Island store is Trulieve's third dispensary in Collier County and its eighth location within Southwest Florida's five-county region (Collier, Lee, Charlotte, Sarasota, Manatee). The regional build-out mirrors Trulieve's strategy in the I-4 corridor, where the company operates 19 stores between Tampa and Orlando to create overlapping 15-minute drive-time zones.

Collier County issued 4,890 new medical cannabis patient cards in the 12 months ending June 2026, a 19% increase from the prior year, per OMMU data. Marco Island's 18,000 residents represent just 1.7% of the county's population but account for 6.4% of new patient registrations, driven by the city's retiree demographic and high prevalence of chronic pain conditions. Thirty-one percent of residents report arthritis or joint pain, versus 22% statewide.

Trulieve's nearest competitors in the Marco Island trade area are a Curaleaf store 8.2 miles north in Naples and a MÜV dispensary 11 miles northeast in East Naples. Both opened in 2025.

Florida's 2024 Vertical Integration Repeal Reshapes Competitive Map

Florida's legislature repealed the state's vertical-integration requirement in May 2024, allowing new entrants to operate dispensaries without owning cultivation facilities. The policy shift, codified in SB 1698, took effect January 1, 2025 and has since enabled 47 new retail-only operators to enter the market, according to Florida Department of Health licensing records.

These independents—many backed by private equity or operating as franchisees under brands like Cannabist and The Flowery—are clustering in high-traffic urban corridors where Trulieve previously faced limited competition. The result? Trulieve's average drive-time advantage (the distance a patient must travel to reach the nearest competing dispensary) has shrunk from 12.3 minutes in Q1 2025 to 7.8 minutes in Q2 2026 across its Florida footprint.

Trulieve hasn't announced plans to wholesale its cultivation output to third-party retailers, a strategy Curaleaf and Verano have both adopted to monetize excess capacity. Rivers said on the earnings call that the company is "evaluating all options" but prioritizes supplying its own stores first.

What Comes Next for Trulieve's Florida Expansion

Trulieve plans to open 12-15 additional Florida dispensaries by year-end 2026, targeting counties where its store density lags competitors. The company has pending applications for locations in Hernando, Flagler, and Walton counties, per state licensing filings. CFO Alex D'Amico said on the Q2 call that capex for Florida retail expansion will total $8 million to $11 million in the second half of 2026, below the $14 million spent in H1.

Florida's Division of Elections will certify Amendment 3 ballot language by August 15. If the amendment survives legal challenge and appears on the November ballot, Trulieve's Florida strategy hinges on a 60% yes vote. If it fails, the company faces a longer grind defending medical-only market share against better-capitalized competitors. We'll be watching the certification deadline and any Attorney General litigation moves through late August.

For full background on Trulieve's Florida footprint and Amendment 3 dynamics, see the CannIntel topic hub on Trulieve Florida expansion.